Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03716479 · ClinicalTrials.gov registry record · NA

Gum Acacia and Blood Glucose

A NA study of Diet Modification, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT03716479: Completed NA study of Diet Modification, sponsored by University of Minnesota.

NCT03716479 is a NA study of Diet Modification that has completed, run by University of Minnesota. The registered enrollment target is 48 participants, below the 13,238-participant average among 19 other Diet Modification trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03716479, a NA study of Diet Modification, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

This study will provide needed insight on the satiety and blood glucose and l effects of the soluble fiber gum acacia at 20g and 40g doses.

Primary Outcome

Blood will be taken via finger stick

Conditions Studied

Interventions

  • OTHER Low Fiber
  • OTHER High Fiber
  • OTHER Placebo/Control

Study Locations (1)

Minnesota

  • Department of Food Science and Nutrition - Saint Paul

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2018-10-09
Est. Completion 2019-09-01
Phase NA
University of Minnesota

966 total trials

What the finished NCT03716479 record still lists

NCT03716479 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 13,238-participant average among 19 other Diet Modification trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Diet Modification appearing as the primary indexed condition, and to 3 interventions - of which Low Fiber is the first listed.

NCT03716479 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT03716479 about?

NCT03716479 is a clinical study titled "Gum Acacia and Blood Glucose". This study will provide needed insight on the satiety and blood glucose and l effects of the soluble fiber gum acacia at 20g and 40g doses.

What is the current status of trial NCT03716479?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-10-09. Estimated completion is 2019-09-01.

What conditions does trial NCT03716479 study?

This clinical trial studies the following conditions: Diet Modification.

What interventions are being tested in trial NCT03716479?

The interventions under investigation include: Low Fiber (OTHER), High Fiber (OTHER), Placebo/Control (OTHER).

Who is sponsoring clinical trial NCT03716479?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03716479 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diet Modification

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03716479's enrollment target sits among peer trials

48 10th of 19 higher than 10 of 19 other Diet Modification trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diet Modification trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03716479, the US trial registry maintained by the National Library of Medicine. NCT03716479 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.